Gå ubegrenset med Magzter GOLD

Gå ubegrenset med Magzter GOLD

Få ubegrenset tilgang til over 9000 magasiner, aviser og premiumhistorier for bare

$149.99
 
$74.99/År

Prøve GULL - Gratis

Quantum Sensing and Healthcare: Charting India's Next Frontier

Bio Spectrum

|

August 2025

Quantum sensing can revolutionise healthcare by enabling early disease detection, precise diagnostics, and customized treatment plans. It detects subtle changes in fields, improving diagnoses for various diseases.

- Ravi Puvvala, MD, Quantum Biosciences Private Limited, India

Quantum Sensing and Healthcare: Charting India's Next Frontier

Technological advances in controlling the world of the ultra-small, made over the past few decades, have brought to fruition a field called “Quantum Sensing.” While it has applicability in a wide variety of problems, medical-diagnostics and healthcare-innovation would be revolutionised. Quantum sensors are ultrasensitive devices, capable of detecting the faintest of biological signals—be they magnetic, electric, thermal or even mechanical. They could enable game-changing applications in real-time diagnostics by detecting or measuring phenomena within single cells that were previously undetectable.

With a strategic investment in research, infrastructure, and translational pathways, India is today presented with a golden opportunity to play a leading role in this emerging domain, radically improving healthcare outcomes and building a global leadership in healthcare technologies.

National Quantum Mission: Catalysing Quantum Healthcare

India's National Quantum Mission (NQM), anchored in T-hubs like Indian Institute of Science (IISc) Bengaluru, Indian Institute of Technology (IIT) Madras, IIT Mumbai, IIT Delhi, has laid the groundwork for innovation across several domains in the field of Quantum Technology. To unlock the full potential for a revolutionary impact on healthcare, the NQM ought to give a high priority to the utilisation of quantum sensing for the biomedical field. A few example applications might include NV center-based subcellular imaging, optically pumped magnetometer (OPM)-driven brain scans, and quantum sensors for tissue oxygenation and metabolism etc. A clearly developed roadmap involving partnerships between the specialised academic establishment with leading clinics, regulatory integration, and funding for translational research could easily position India at the forefront of international players in this field.

Elevate Karnataka: Accelerating Deep-Tech Startups

FLERE HISTORIER FRA Bio Spectrum

Bio Spectrum

Bio Spectrum

India's Pharma Reforms Target Global Credibility

The Indian government has introduced several measures to simplify drug approvals and support innovation.

time to read

9 mins

October 2025

Bio Spectrum

Bio Spectrum

How Waste Management Strategies Can Transform Indian Pharma Manufacturing

Sustainability will be a key success factor as India's pharmaceutical industry enters its next stage of expansion.

time to read

7 mins

October 2025

Bio Spectrum

Bio Spectrum

IASST synthesises new compound to combat aggressive breast cancer

A newly designed nitro-substituted organoselenium compound by Guwahati-based Institute of Advanced Study in Science and Technology (IASST), an autonomous institute under the Department of Science and Technology (DST), can reduce the invasiveness of aggressive triplenegative breast cancer cells by modulating various Se Se signalling pathways.

time to read

1 min

October 2025

Bio Spectrum

DPIIT signs MoU with Pfizer to strengthen healthcare innovation ecosystem

In a significant step towards strengthening India's healthcare innovation ecosystem, the Department for Promotion of Industry and Internal Trade (DPIIT), Ministry of Commerce and Industry, has signed a Memorandum of Understanding (MoU) with Pfizer Limited.

time to read

1 min

October 2025

Bio Spectrum

Bio Spectrum

WHO unveils updated guideline on HIV service delivery

WHO has released an updated guideline to support integrated HIV service delivery, promote long-term adherence to antiretroviral therapy (ART), and improve the overall health and well-being of people living with HIV.

time to read

1 min

October 2025

Bio Spectrum

Scientists in Kolkata explore therapeutic potential of accessory proteins

A hidden protein that protects our cells from mechanical stress could provide a new direction to therapeutic strategies for diseases where protein stability under force is compromised like heart muscle disease or genetic disorders called laminopathies.

time to read

1 min

October 2025

Bio Spectrum

Bio Spectrum

US FDA advances rare disease drug development

The US Food and Drug Administration (FDA) has introduced the Rare Disease Evidence Principles (RDEP) to provide greater speed and predictability in the review of therapies intended to treat rare diseases with very small patient populations with significant unmet medical need and that are driven by a known genetic defect.

time to read

1 min

October 2025

Bio Spectrum

WHO updates list of essential medicines to include key cancer, diabetes treatments

The World Health Organization (WHO) has released updated editions of its Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLC), adding new treatments for various types of cancer and for diabetes with associated comorbidities such as obesity.

time to read

1 min

October 2025

Bio Spectrum

Agilent's MMR IHC Panel pharmDx (Dako Omnis) receives European IVDR Certification

Agilent Technologies Inc. has announced that its MMR IHC Panel pharmDx (Dako Omnis) has received class C companion diagnostic (CDx) certification under EU in vitro diagnostic regulation (IVDR)1 as a CDx test for colorectal cancer.

time to read

1 min

October 2025

Bio Spectrum

Aodh Lifesciences gets support from TDB to redefine pneumonia treatment

The Technology Development Board (TDB), Department of Science and Technology, Government of India, has extended support to Aodh Lifesciences, a startup based in Hyderabad, for development of Indigenous Antibiotic Nebulisation Suspension for Pneumonia (AONEUM-04) and Antimicrobial Resistance (AMR).

time to read

1 min

October 2025

Listen

Translate

Share

-
+

Change font size